SCHEMBL26458337

SCHEMBL26458337

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c(c3)C3(c5ccccc5Oc5ccccc53)c3cc(-c5cnc6ccccc6n5)ccc3-4)n2)cc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 10/20 0.43
RAB9A P51151 8/20 0.43
KMT2A Q03164 2/20 0.41
SMN1; SMN2 Q16637 4/20 0.40
BCHE P06276 1/20 0.40
JAK2 O60674 2/20 0.40
MAPT P10636 3/20 0.40
ALDH1A1 P00352 1/20 0.40
GLA P06280 1/20 0.40
GAA P10253 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
PDGFRB P09619 1/20 0.39
KDR P35968 1/20 0.39
FLT3 P36888 1/20 0.39
TLR9 Q9NR96 1/20 0.38
TP53 P04637 1/20 0.37
STAT1 P42224 1/20 0.37
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26458296 0.96 NPC1 (0.43) NPC1RAB9AKMT2ASMN1; SMN2BCHE
SCHEMBL26458556 0.91 NPC1 (0.42) NPC1RAB9AKMT2ASMN1; SMN2BCHE
SCHEMBL26458393 0.90 NPC1 (0.38) NPC1RAB9AKMT2ASMN1; SMN2BCHE
SCHEMBL14278911 0.88 NPC1 (0.45) NPC1RAB9AKMT2ASMN1; SMN2BCHE
SCHEMBL26458253 0.88 NPC1 (0.37) NPC1RAB9AKMT2ASMN1; SMN2BCHE
SCHEMBL26458343 0.88 MEN1 (0.41) NPC1RAB9AKMT2ASMN1; SMN2MAPT
SCHEMBL26458363 0.87 MEN1 (0.41) NPC1RAB9AKMT2ASMN1; SMN2MAPT
SCHEMBL19299226 0.86 NPC1 (0.47) NPC1RAB9AKMT2ASMN1; SMN2BCHE
SCHEMBL26458347 0.86 MEN1 (0.48) KMT2ASMN1; SMN2MAPTALDH1A1GLA
SCHEMBL22216553 0.85 PDK2 (0.40) KMT2AMAPTALDH1A1GLAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11641778-B2 Compound and organic light emitting device comprising same LG CHEM, LTD. (KR) 2023-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11641778-B2 Compound and organic light emitting device comprising same CRY1, CYP1A1, CRY2 NPC1 1521/4885RAB9A 2344/4885KMT2A 1182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.